# Cetirizine hydrochloride

NDC: 62207-764
Generic name: Cetirizine hydrochloride
Labeler / Manufacturer: Granules India Ltd
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20180528

FDA application: ANDA209274

## Active ingredients

- CETIRIZINE HYDROCHLORIDE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62207-764"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62207-764
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6efd5a60-e281-43f9-a52c-a95f46fbcbfc